Resistance to antimicrobial chemotherapy: a prescription for research and action.
暂无分享,去创建一个
S Bonhoeffer | L Simonsen | M. Nowak | B. Levin | M. Lipsitch | S. Bonhoeffer | R. Tauxe | J. Mcgowan | F. Tenover | P. Bloland | R. Antia | P. Fields | T. Porco | R Antia | J E McGowan | F Tenover | M Lipsitch | H. Jafari | B R Levin | M. Cohen | M Nowak | J. Spitznagel | E Berliner | P Bloland | M Cohen | T DeRouin | P I Fields | H Jafari | D Jernigan | P Mead | T Porco | P Sykora | J Spitznagel | R Tauxe | D. Jernigan | P. Mead | P. Sykora | L. Simonsen | E. Berliner | T. Derouin
[1] C. L. Moberg. Special Article: René Dubos: A Harbinger of Microbial Resistance to Antibiotics , 1996 .
[2] Alan S. Perelson,et al. Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.
[3] C. L. Moberg. René Dubos, a Harbinger of Microbial Resistance to Antibiotics , 2015, Microbial drug resistance.
[4] J. Cohen. Vaccines get a new twist. , 1994, Science.
[5] M A Nowak,et al. Pre-existence and emergence of drug resistance in HIV-1 infection. , 1997, Proceedings. Biological sciences.
[6] M A Nowak,et al. Virus dynamics and drug therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[7] R. Hawkins,et al. Discovery of antibodies. , 1992, BMJ.
[8] P Huovinen,et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. , 1997, The New England journal of medicine.
[9] M Kakehashi,et al. The transmission dynamics of antibiotic–resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption , 1997, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[10] R. O'brien,et al. USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results. , 1990, Annals of internal medicine.
[11] H. Neu,et al. The Crisis in Antibiotic Resistance , 1992, Science.
[12] F. M. Stewart,et al. The population genetics of antibiotic resistance. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] M A Nowak,et al. Human immunodeficiency virus drug therapy and virus load , 1997, Journal of virology.
[14] R. Danner,et al. Anti-endotoxin monoclonal antibodies. , 1992, The New England journal of medicine.
[15] S. Blower,et al. Control Strategies for Tuberculosis Epidemics: New Models for Old Problems , 1996, Science.
[16] T. Mckeown. The Role of Medicine , 1979 .
[17] A. Tomasz,et al. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. , 1994, The New England journal of medicine.
[18] M A Nowak,et al. Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations. , 1997, Journal of theoretical biology.
[19] B. Levin,et al. The population dynamics of antimicrobial chemotherapy , 1997, Antimicrobial agents and chemotherapy.
[20] D. Burke. Vaccine therapy for HIV: a historical review of the treatment of infectious diseases by active specific immunization with microbe-derived antigens. , 1993, Vaccine.
[21] B. Levin,et al. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli , 1997, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[22] S. Levy,et al. High frequency of antimicrobial resistance in human fecal flora , 1988, Antimicrobial Agents and Chemotherapy.
[23] H. Smith,et al. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. , 1983, Journal of general microbiology.
[24] D. Gordon,et al. Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. , 1985, The American journal of gastroenterology.
[25] Christopher J. L. Murray,et al. Tuberculosis: Commentary on a Reemergent Killer , 1992, Science.
[26] S. Levy. Balancing the drug-resistance equation. , 1994, Trends in microbiology.
[27] S. Paulous,et al. Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drug. , 1996, The Journal of general virology.
[28] M A Nowak,et al. Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[29] R. Dubos,et al. THE MULTIPLICATION OF BACTERIOPHAGE IN VIVO AND ITS PROTECTIVE EFFECT AGAINST AN EXPERIMENTAL INFECTION WITH SHIGELLA DYSENTERIAE , 1943, The Journal of experimental medicine.
[30] S. Schrag,et al. Reducing antibiotic resistance , 1996, Nature.
[31] E Massad,et al. Modeling and simulating the evolution of resistance against antibiotics. , 1993, International journal of bio-medical computing.
[32] P Huovinen,et al. Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] Julian Adams,et al. COEVOLUTION IN BACTERIAL‐PLASMID POPULATIONS , 1991, Evolution; international journal of organic evolution.
[34] J. Hughes,et al. Trends in antimicrobial drug prescribing among office-based physicians in the United States. , 1995, JAMA.
[35] H. Smith,et al. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. , 1982, Journal of general microbiology.
[36] M. Kimura,et al. An introduction to population genetics theory , 1971 .
[37] J. Mcgowan,et al. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. , 1983, Reviews of infectious diseases.
[38] K. M. Shaw,et al. The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. , 1987, Journal of general microbiology.
[39] E. Zell,et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. , 1993, JAMA.
[40] J. E. Bouma,et al. Evolution of a bacteria/plasmid association , 1988, Nature.
[41] S. Lindsay,et al. The effect of insecticide-treated bed nets on mortality of Gambian children , 1991, The Lancet.
[42] J. Mcgowan,et al. Control of antimicrobial resistance in the health care system. , 1997, Infectious disease clinics of North America.
[43] M. Pfaller,et al. The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study. , 1995, American journal of infection control.
[44] S Bonhoeffer,et al. Evaluating treatment protocols to prevent antibiotic resistance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[45] Mitchell L. Cohen. Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era , 1992, Science.
[46] R. Nelson,et al. Recolonization Therapy with Nonadhesive Escherichia coli for Treatment of Inflammatory Bowel Disease , 1994, Annals of the New York Academy of Sciences.
[47] M. Finland. Adventures with antibacterial drugs , 1972, Clinical pharmacology and therapeutics.
[48] A. Tomasz,et al. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. , 1991, The Journal of infectious diseases.
[49] L. Mcfarland,et al. Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters , 1987, Antimicrobial Agents and Chemotherapy.
[50] S. Frost,et al. Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV infection , 1994, AIDS.
[51] F. Tenover,et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. , 1997, The Journal of antimicrobial chemotherapy.